{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T22:55:25Z","timestamp":1784847325795,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.suc.2022.04.007","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T19:37:09Z","timestamp":1659987429000},"page":"679-693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Benign Neurogenic Tumors"],"prefix":"10.1016","volume":"102","author":[{"given":"Jeffrey M.","family":"Farma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea S.","family":"Porpiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine T.","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.suc.2022.04.007_bib1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2214\/ajr.164.2.7839977","article-title":"Benign soft-tissue tumors in a large referral population: distribution of specific diagnoses by age, sex, and location","volume":"164","author":"Kransdorf","year":"1995","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.suc.2022.04.007_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/rg.231025050","article-title":"Neurogenic tumors in the abdomen: tumor types and imaging characteristics","volume":"23","author":"Rha","year":"2003","journal-title":"Radiographics"},{"issue":"8","key":"10.1016\/j.suc.2022.04.007_bib3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1055\/s-0040-1712499","article-title":"Primary intrathoracic neurogenic tumors: clinical, pathological, and long-term outcomes","volume":"69","author":"Galetta","year":"2021","journal-title":"Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.suc.2022.04.007_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nec.2004.02.006","article-title":"Operative outcomes of 546 Louisiana State University Health Sciences Center peripheral nerve tumors","volume":"15","author":"Kim","year":"2004","journal-title":"Neurosurg Clin N Am"},{"issue":"1","key":"10.1016\/j.suc.2022.04.007_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejrad.2011.04.036","article-title":"Peripheral tumor and tumor-like neurogenic lesions","volume":"82","author":"Abreu","year":"2013","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.suc.2022.04.007_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1055\/s-0038-1676290","article-title":"Nerve Tumors: What the MSK Radiologist Should Know","volume":"23","author":"Tagliafico","year":"2019","journal-title":"Semin Musculoskelet Radiol"},{"issue":"2","key":"10.1016\/j.suc.2022.04.007_bib7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7","article-title":"The International Neuroblastoma Pathology Classification (the Shimada system)","volume":"86","author":"Shimada","year":"1999","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.suc.2022.04.007_bib8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1148\/radiographics.22.4.g02jl15911","article-title":"Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation","volume":"22","author":"Lonergan","year":"2002","journal-title":"Radiographics"},{"issue":"23","key":"10.1016\/j.suc.2022.04.007_bib9","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.suc.2022.04.007_bib10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40618-014-0226-y","article-title":"Incidental ganglioneuromas: a presentation of 14 surgical cases and literature review","volume":"38","author":"Spinelli","year":"2015","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.suc.2022.04.007_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cen.14297","article-title":"Ganglioneuromas across age groups: Systematic review of individual patient data","volume":"94","author":"Fliedner","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.suc.2022.04.007_bib12","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3892\/etm.2021.10773","article-title":"Adrenal ganglioneuroma: Prognostic factors (Review)","volume":"22","author":"Sandru","year":"2021","journal-title":"Exp Ther Med"},{"issue":"2","key":"10.1016\/j.suc.2022.04.007_bib13","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.suc.2022.04.007_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.suc.2022.04.007_bib15","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.suc.2022.04.007_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijscr.2015.11.004","article-title":"Retroperitoneal non-functioning paraganglioma: A difficult tumour to diagnose and treat","volume":"17","author":"Gannan","year":"2015","journal-title":"Int J Surg Case Rep"},{"issue":"24","key":"10.1016\/j.suc.2022.04.007_bib17","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.3748\/wjg.15.3003","article-title":"Clinicopathological analysis of paraganglioma with literature review","volume":"15","author":"Feng","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.suc.2022.04.007_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1196\/annals.1353.059","article-title":"Pathology of pheochromocytoma and extra-adrenal paraganglioma","volume":"1073","author":"Tischler","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.suc.2022.04.007_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/1096-9098(200008)74:4<286::AID-JSO9>3.0.CO;2-C","article-title":"Paragangliomas-- a decade of clinical experience","volume":"74","author":"Somasundar","year":"2000","journal-title":"J\u00a0Surg Oncol"},{"issue":"3","key":"10.1016\/j.suc.2022.04.007_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000100392","article-title":"Paragangliomas of the head and neck","volume":"16","author":"Isik","year":"2007","journal-title":"Med Princ Pract"},{"issue":"1","key":"10.1016\/j.suc.2022.04.007_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1530\/EJE-20-0628","article-title":"Epidemiology of pheochromocytoma and paraganglioma: population-based cohort study","volume":"184","author":"Leung","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.suc.2022.04.007_bib22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1245\/s10434-013-2942-5","article-title":"Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing","volume":"20","author":"Fishbein","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.suc.2022.04.007_bib23","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1210\/jc.2017-00992","article-title":"Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years","volume":"102","author":"Hamidi","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.suc.2022.04.007_bib24","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1210\/jc.2008-2756","article-title":"Genetics of pheochromocytoma and paraganglioma in Spanish patients","volume":"94","author":"Cascon","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.suc.2022.04.007_bib25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MPA.0000000000001792","article-title":"The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and\/or Unresectable Pheochromocytoma and Paraganglioma","volume":"50","author":"Fishbein","year":"2021","journal-title":"Pancreas"},{"issue":"9486","key":"10.1016\/j.suc.2022.04.007_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.suc.2022.04.007_bib27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1410619","article-title":"Pheochromocytoma in Italy: a multicentric retrospective study","volume":"141","author":"Mannelli","year":"1999","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.suc.2022.04.007_bib28","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjsurg.2010.04.012","article-title":"Malignant pheochromocytoma: a review","volume":"201","author":"Harari","year":"2011","journal-title":"Am J Surg"},{"issue":"6","key":"10.1016\/j.suc.2022.04.007_bib29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00000658-199906000-00001","article-title":"Clinical experience over 48 years with pheochromocytoma","volume":"229","author":"Goldstein","year":"1999","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.suc.2022.04.007_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/jso.23297","article-title":"Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades","volume":"107","author":"Goffredo","year":"2013","journal-title":"J\u00a0Surg Oncol"},{"issue":"6","key":"10.1016\/j.suc.2022.04.007_bib31","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1210\/jc.2018-01968","article-title":"Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study","volume":"104","author":"Hescot","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.suc.2022.04.007_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-13-0494","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Kimura","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.suc.2022.04.007_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0025-7125(16)30088-8","article-title":"Pheochromocytoma. Update on diagnosis, localization, and management","volume":"79","author":"Werbel","year":"1995","journal-title":"Med Clin North Am"},{"issue":"4","key":"10.1016\/j.suc.2022.04.007_bib34","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1210\/jc.2004-2025","article-title":"Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine","volume":"90","author":"Eisenhofer","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.suc.2022.04.007_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1022981801344","article-title":"Pheochromocytoma as an endocrine emergency","volume":"4","author":"Brouwers","year":"2003","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"10.1016\/j.suc.2022.04.007_bib36","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and Paraganglioma","volume":"381","author":"Neumann","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.suc.2022.04.007_bib37","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/archinte.1992.00400180061009","article-title":"The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls","volume":"152","author":"Sjoberg","year":"1992","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.suc.2022.04.007_bib38","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s00259-015-3268-2","article-title":"Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET\/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases","volume":"43","author":"Archier","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.suc.2022.04.007_bib39","doi-asserted-by":"crossref","first-page":"586795","DOI":"10.3389\/fendo.2020.586795","article-title":"Preoperative management of pheochromocytoma and paraganglioma","volume":"11","author":"Fang","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.suc.2022.04.007_bib40","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/01.sla.0000164175.26785.06","article-title":"Laparoscopic curative resection of pheochromocytomas","volume":"241","author":"Kercher","year":"2005","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.suc.2022.04.007_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12893-020-00824-6","article-title":"Laparoscopic versus open surgery for pheochromocytoma: a meta-analysis","volume":"20","author":"Fu","year":"2020","journal-title":"BMC Surg"},{"issue":"13","key":"10.1016\/j.suc.2022.04.007_bib42","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1245\/s10434-013-3134-z","article-title":"Robotic versus laparoscopic adrenalectomy for pheochromocytoma","volume":"20","author":"Aliyev","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.suc.2022.04.007_bib43","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s12020-021-02843-6","article-title":"Surgical outcomes in the pheochromocytoma surgery. Results from the PHEO-RISK STUDY","volume":"74","author":"Araujo-Castro","year":"2021","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.suc.2022.04.007_bib44","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2967\/jnumed.118.217463","article-title":"Efficacy and Safety of High-Specific-Activity (131)I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma","volume":"60","author":"Pryma","year":"2019","journal-title":"J\u00a0Nucl Med"},{"issue":"11","key":"10.1016\/j.suc.2022.04.007_bib45","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1002\/cncr.26577","article-title":"Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience","volume":"118","author":"Ayala-Ramirez","year":"2012","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.suc.2022.04.007_bib46","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1245\/s10434-020-08221-2","article-title":"Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma","volume":"27","author":"Patel","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2022.04.007_bib47","series-title":"Histology, Schwann cells","author":"Fallon","year":"2022"},{"issue":"1","key":"10.1016\/j.suc.2022.04.007_bib48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjsurg.2005.12.010","article-title":"Retroperitoneal schwannoma","volume":"192","author":"Goh","year":"2006","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.suc.2022.04.007_bib49","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1148\/radiographics.19.5.g99se101253","article-title":"From the archives of the AFIP. Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic correlation","volume":"19","author":"Murphey","year":"1999","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.suc.2022.04.007_bib50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/bpa.12125","article-title":"Schwannomas and their pathogenesis","volume":"24","author":"Hilton","year":"2014","journal-title":"Brain Pathol"},{"issue":"11","key":"10.1016\/j.suc.2022.04.007_bib51","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.3390\/ijms22115850","article-title":"Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis","volume":"22","author":"Tamura","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6429","key":"10.1016\/j.suc.2022.04.007_bib52","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2","volume":"363","author":"Rouleau","year":"1993","journal-title":"Nature"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610922000421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610922000421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:13:47Z","timestamp":1758539627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610922000421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0039610922000421"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2022.04.007","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benign Neurogenic Tumors","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2022.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}